The Peripheral(-Muscle) Oxygenation and Perfusion Score as a New Non-invasive Tool to Predict Elevations in C-reactive Protein Levels in Neonates

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-6
SponsorMedical University of Graz

About this trial

This is a prospective, single-center Phase II observational study investigating the predictive value of the "Peripheral(-muscle) Oxygenation and Perfusion Score" (POP-Score), a novel non-invasive composite index, for early detection of infection/inflammation in neonates. The POP-Score combines peripheral muscle oxygenation measured via near-infrared spectroscopy (NIRS) with routinely monitored clinical parameters (heart rate, oxygen saturation, systolic blood pressure, and subcutaneous fat thickness). The study aims to determine the optimal cut-off value of the POP-Score measured within the first 6 hours after birth to predict elevated C-reactive protein (CRP ≥20 mg/L) within 48 hours. Additionally, multi-site NIRS measurements (cerebral, peripheral muscle, intestinal, and flank) will be evaluated to assess their association with inflammation. The study includes term and moderate-to-late preterm neonates (birth weight ≥2000g) with respiratory distress, admitted to the neonatal intensive care unit at the Medical University of Graz.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

birth weight ≥ 2000 grams

Signs of respiratory distress at time-point of inclusion (tachypnoea >60/min, grunting, intercostal/subcostal/jugular retractions, nasal flaring, supplemental oxygen or respiratory support)

Decision to conduct full life support

Written informed consent obtained within the first 6 hours after birth, before inclusion in the study

Disqualifiers

No decision to conduct full life support

No written informed consent

Birth weight < 2000 grams

Age > 6 hours

Trial population

Term and moderate-to-late preterm neonates (birth weight ≥ 2000 grams) with signs of respiratory distress within the first 6 hours after birth, admitted to the neonatal intensive care unit at the Medical University of Graz. All participants must have a gestational age allowing for clinical stability and must meet inclusion criteria including full life support decision and informed consent obtained within 6 hours of birth.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • POP-Score Assessment

    Diagnostic test

    A non-invasive score calculated within the first 6 hours after birth using peripheral muscle oxygenation (pTOI, measured via near-infrared spectroscopy), heart rate, arterial oxygen saturation (SpO2), systolic blood pressure (SABP), and subcutaneous fat layer thickness. The score is evaluated for its ability to predict C-reactive protein (CRP) levels ≥ 20 mg/L within 48 hours.

  • Near-Infrared Spectroscopy (NIRS)

    Device

    NIRS measurements are performed within 6 hours after birth using the NIRO 200NX device at four anatomical sites (forearm, forehead, infraumbilical region, and left flank). Measurements assess peripheral muscle, cerebral, intestinal, and flank oxygenation to identify possible differences in tissue perfusion associated with early inflammation or infection.

Treatment groups

93 Participants
are divided into 1 treatment group
Group A: Observational cohort2 interventions

Trial outcomes

Primary outcomes

1

Optimal Cut-Off Value of the POP-Score to Predict Elevated CRP (≥ 20 mg/L)

Determine the optimal cut-off value of the non-invasive POP-Score (unitless score), measured within the first 6 hours after birth, to predict elevated C-reactive protein (CRP) levels (≥ 20 mg/L) within the first 48 hours after birth in neonates with respiratory distress.

Time frame
Within the first 6 hours after birth (parameters of the POP-Score) and CRP within 48 hours

Secondary outcomes

1

Difference in Peripheral Muscle Tissue Oxygenation by NIRS Between Neonates With and Without Elevated CRP

Evaluate whether there are significant differences in peripheral muscle tissue oxygenation values measured via near-infrared spectroscopy (NIRS) within the first 6 hours after birth between neonates with elevated CRP levels (≥ 20 mg/L) and those with CRP \< 20 mg/L. Unit of Measure: % tissue oxygen saturation

Time frame
NIRS within 6 hours after birth; CRP within 48 hours
2

Difference in Cerebral Tissue Oxygenation by NIRS Between Neonates With and Without Elevated CRP

Evaluate whether there are significant differences in cerebral tissue oxygenation values measured via near-infrared spectroscopy (NIRS) within the first 6 hours after birth between neonates with elevated CRP levels (≥ 20 mg/L) and those with CRP \< 20 mg/L. Unit of Measure: % tissue oxygen saturation

Time frame
NIRS within 6 hours after birth; CRP within 48 hours
3

Difference in Intestinal Tissue Oxygenation by NIRS Between Neonates With and Without Elevated CRP

Evaluate whether there are significant differences in intestinal tissue oxygenation values measured via near-infrared spectroscopy (NIRS) within the first 6 hours after birth between neonates with elevated CRP levels (≥ 20 mg/L) and those with CRP \< 20 mg/L. Unit of Measure: % tissue oxygen saturation

Time frame
NIRS within 6 hours after birth; CRP within 48 hours
4

Difference in Flank Tissue Oxygenation by NIRS Between Neonates With and Without Elevated CRP

Evaluate whether there are significant differences in flank tissue oxygenation values measured via near-infrared spectroscopy (NIRS) within the first 6 hours after birth between neonates with elevated CRP levels (≥ 20 mg/L) and those with CRP \< 20 mg/L. Unit of Measure: % tissue oxygen saturation

Time frame
NIRS within 6 hours after birth; CRP within 48 hours

Other outcomes

1

Difference in Cerebral Fractional Tissue Oxygen Extraction (cFTOE) Between Neonates With and Without Elevated CRP

Assess whether there are significant differences in cerebral fractional tissue oxygen extraction (cFTOE) values, derived from near-infrared spectroscopy (NIRS), within the first 6 hours after birth between neonates with elevated CRP levels (≥ 20 mg/L) and those with CRP \< 20 mg/L. Unit of Measure: Unitless ratio

Time frame
FTOE within 6 hours after birth; CRP within 48 hours
2

Difference in Peripheral Muscle Fractional Tissue Oxygen Extraction (pFTOE) Between Neonates With and Without Elevated CRP

Assess whether there are significant differences in peripheral muscle fractional tissue oxygen extraction (pFTOE) values, derived from NIRS, within the first 6 hours after birth between neonates with elevated CRP levels (≥ 20 mg/L) and those with CRP \< 20 mg/L. Unit of Measure: Unitless ratio

Time frame
FTOE within 6 hours after birth; CRP within 48 hours
3

Difference in Intestinal Fractional Tissue Oxygen Extraction (sFTOE) Between Neonates With and Without Elevated CRP

Assess whether there are significant differences in intestinal fractional tissue oxygen extraction (sFTOE) values, derived from NIRS, within the first 6 hours after birth between neonates with elevated CRP levels (≥ 20 mg/L) and those with CRP \< 20 mg/L. Unit of Measure: Unitless ratio

Time frame
FTOE within 6 hours after birth; CRP within 48 hours
4

Difference in Flank Fractional Tissue Oxygen Extraction (rFTOE) Between Neonates With and Without Elevated CRP

Assess whether there are significant differences in flank fractional tissue oxygen extraction (rFTOE) values, derived from NIRS, within the first 6 hours after birth between neonates with elevated CRP levels (≥ 20 mg/L) and those with CRP \< 20 mg/L. Unit of Measure: Unitless ratio

Time frame
FTOE within 6 hours after birth; CRP within 48 hours

Sponsors and contacts

Click on the lead sponsor to view all of their trials.